Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s stock price hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.33 and last traded at C$0.33, with a volume of 159100 shares traded. The stock had previously closed at C$0.34.
Nanalysis Scientific Stock Performance
The company has a market cap of C$36.74 million, a PE ratio of -2.79 and a beta of 0.72. The business’s 50-day moving average is C$0.37 and its 200 day moving average is C$0.40. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Recommended Stories
- Five stocks we like better than Nanalysis Scientific
- What does consumer price index measure?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- With Risk Tolerance, One Size Does Not Fit All
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
